...
首页> 外文期刊>Clinical and vaccine immunology: CVI >Validation of a medium-throughput method for evaluation of intracellular growth of Mycobacterium tuberculosis.
【24h】

Validation of a medium-throughput method for evaluation of intracellular growth of Mycobacterium tuberculosis.

机译:medium-throughput方法的验证评价细胞的增长结核分枝杆菌。

获取原文
获取原文并翻译 | 示例
           

摘要

Intracellular pathogens such as Mycobacterium tuberculosis have adapted to a life inside host cells, in which they utilize host nutrients to replicate and spread. Ineffective methods for the evaluation of growth of intracellular pathogens in their true environment pose an obstacle for basic research and drug screening. Here we present the validation of a luminometry-based method for the analysis of intramacrophage growth of M. tuberculosis. The method, which is performed in a medium-throughput format, can easily be adapted for studies of other intracellular pathogens and cell types. The use of host cells in drug-screening assays dedicated to find antimicrobials effective against intracellular pathogens permits the discovery of not only novel antibiotics but also compounds with immunomodulatory and virulence-impairing activities, which may be future alternatives or complements to antibiotics.
机译:胞内分枝杆菌等病原体肺结核已经适应了生活在主机上他们利用宿主细胞,营养复制和传播。评价细胞内病原体的生长在他们的真实环境中造成障碍基础研究和药物筛选。luminometry-based的验证方法分析intramacrophage增长结核分枝杆菌。medium-throughput格式执行,可以很容易适应的研究细胞内病原体和细胞类型。筛查检测专用的宿主细胞找到抗菌素有效对抗细胞内病原体允许的发现不仅小说抗生素,而且化合物免疫调节和virulence-impairing活动,这可能是未来的替代品或对抗生素的补充。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号